Objective-We and others have previously shown that RhoA-dependent stimulation of myocardin-related transcription factor nuclear localization promotes smooth muscle cell (SMC) marker gene expression. The goal of this study was to provide direct in vivo evidence that actin polymerization by the diaphanous-related formins contributes to the regulation of SMC differentiation and phenotype. Approach and Results-Conditional Cre-based genetic approaches were used to overexpress a well-characterized dominantnegative variant of mDia1 (DNmDia) in SMC. DNmDia expression in SM22-expressing cells resulted in embryonic and perinatal lethality in ≈20% of mice because of defects in myocardial development and SMC investment of peripheral vessels. Although most DNmDia + /SM22Cre + mice exhibited no overt phenotype, the re-expression of SMC differentiation marker gene expression that occurs after carotid artery ligation was delayed, and this effect was accompanied by a significant decrease in myocardin-related transcription factor-A nuclear localization. Interestingly, neointima growth was inhibited by expression of DNmDia in SMC and this was likely because of a defect in directional SMC migration and not to defects in SMC proliferation or survival. Finally, by using the tamoxifen-inducible SM MHC-CreER T2 line, we showed that SMC-specific induction of DNmDia in adult mice decreased SMC marker gene expression. Conclusions-Our demonstration that diaphanous-related formin signaling plays a role in heart and vascular development and the maintenance of SMC phenotype provides important new evidence that Rho/actin/myocardin-related transcription factor signaling plays a critical role in cardiovascular function. The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
S mooth muscle cell (SMC) differentiation plays an important role in vascular development and maintenance. Although medial SMCs express a repertoire of contractileassociated differentiation markers, they do not terminally differentiate even in adult animals. Phenotypically modulated SMC that exhibit decreased differentiation marker gene expression and increased growth, migration, and matrix production have been shown to contribute to the progression of several important cardiovascular diseases, including atherosclerosis, hypertension, and restenosis. 1, 2 Therefore, a better understanding of the signaling mechanisms that control these SMC functions will be critical.
Most SMC differentiation marker genes including SM myosin heavy chain (SM MHC), SM α-actin, calponin, and SM22 are regulated by serum response factor, a ubiquitously expressed MADS (MCM1, agamous, deficiens, SRF) box transcription factor that binds to conserved CArG (CC(A/ T) 6 GG) elements within the promoters of these genes. 2 The cardiac and SMC selective serum response factor cofactor, myocardin, strongly transactivates SMC-specific transcription and is required for SMC differentiation in vivo. 3 Two myocardin-related transcription factors, MRTF-A and MRTF-B, have also been identified. Although they are expressed more widely, their importance in the regulation of SMC differentiation marker gene expression is supported by the phenotypes of global and tissue-specific knockouts. [4] [5] [6] [7] We and others have demonstrated that RhoA-mediated actin polymerization stimulates MRTF nuclear localization and is critical for SMC marker gene expression in at least some SMC types. [8] [9] [10] [11] However, direct in vivo evidence that this mechanism plays a significant role in the regulation of SMC differentiation or phenotypic modulation is lacking.
We have previously identified many signaling mechanisms that control RhoA activity in SMCs 12, 13 and have characterized the pathways downstream of RhoA that regulate MRTF-dependent SMC-specific transcription. 14, 15 The Rhoassociated kinases 1 and 2 increase actin polymerization indirectly through a kinase cascade that inhibits cofilin ability to sever F-actin, and they also promote stress fiber formation by enhancing actin fiber bundling and cell contractility. 16, 17 However, we have shown that inhibition of Rho-associated kinase signaling only partially inhibited SMC-specific promoter activity, suggesting that additional RhoA effectors were important. The diaphanous-related formins (DRFs), mDia1 and mDia2, are RhoA effectors that directly catalyze linear actin polymerization in cooperation with profilin. [18] [19] [20] [21] We have shown that both are highly expressed in SMCs, and when activated, strongly upregulate SMC marker gene expression. 14 Importantly, siRNA-mediated knockdown of mDia1 and mDia2 in primary rat aortic SMCs resulted in a significant reduction in SMC-specific promoter activity, endogenous SMC marker gene expression, and MRTF nuclear localization. 14 RhoA signaling also regulates the actin and adhesion dynamics that control cell migration and division. Using fluorescent biosensors, Pertz et al 22 detected RhoA activity near the leading edge of migrating cells where it is thought to promote actin-based cell protrusion. RhoA activity is also high at the rear of migrating cells where it induces the contractile forces necessary for trailing edge retraction. Several studies have shown that mDia1 and mDia2 catalyze the linear actin polymerization that is required for filopodia formation. 23 RhoA signaling also controls cell adhesion by modulating focal adhesion formation and RhoA-dependent activation of mDia2 at the cleavage furrow may be important for cytokinesis. 24, 25 Given its pleiotropic effects on nearly all the parameters that define SMC phenotype, it will be critical to further study RhoA/mDia/actin signaling in SMCs.
The goal of this study was to define the contributions of mDia-mediated actin polymerization to SMC phenotype in vivo. We used genetic models to inhibit DRF signaling in SMCs during cardiovascular development, and we studied the effects of mDia inhibition on SMC phenotypic modulation in adult mice subjected to carotid artery ligation. Our results indicate that mDia signaling was required for normal cardiovascular development and that inhibition of mDia signaling attenuated SMC differentiation marker gene expression but reduced neointima formation by inhibiting SMC migration.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Inhibition of mDia Signaling in SM22-Expressing Cells Led to Some Embryonic/Perinatal Lethality
To determine the contributions of actin polymerization to the regulation of SMC differentiation or phenotype in vivo, we used a genetic approach to overexpress a dominant-negative variant of mDia1 (F1FHΔ1) specifically in SMCs ( Figure  1A ). Because mDia1 and mDia2 are RhoA effectors with considerable functional overlap, 26, 27 it is important to note that this variant inhibits the function of all DRFs by dimerizing with endogenous proteins or binding nonproductively with barbed actin filaments. 18, 28 Another consideration for our approach was that DNmDia inhibits actin polymerization more specifically than alternative interventions that target Rho and its many effectors or Rho-associated kinase and its many substrates. In excellent agreement with our previous demonstration that DNmDia inhibited the activities of exogenous SMC-specific promoters, 14 overexpression of DNmDia inhibited the endogenous expression of multiple SMC-specific marker genes and the nuclear localization of MRTF-A in S1P-treated 10T1/2 cells ( Figure 1B-D) .
Flag-tagged DNmDia was cloned into a previously described transgene construct in which the constitutive expression of DNmDia (driven by a fragment of the β-actin promoter) is inhibited by the upstream insertion of a floxed EGFP (enhanced green fluorescent protein)-Stop cassette ( Figure 2A ). 29, 30 DNmDia transgenic mice were generated on a C57BL/6 background and were crossed to a well-characterized SM22Cre line 31 that expresses Cre in most SMC subsets and in the developing myocardium ( Figure IA in the online-only Data Supplement). 32 Although many DNmDia + / SM22Cre + mice were viable, the number that reached adulthood was ≈20% less than that expected by Mendelian ratios (Table) . Several DNmDia + /SM22Cre + mice died in utero with nonviable embryos beginning to appear at around E15.5. Hemorrhage was detected in 6 of 17 DNmDia + /SM22Cre + embryos between E15.5 and E18.5 and was most visible near the smaller, more peripheral blood vessels of the head, limbs, and body wall ( Figure 2B ). Immunohistologic examination of these mice revealed severely dilated blood vessels that were poorly invested with SM α-actin-expressing cells ( Figure  2C ). Importantly, SMC coverage of larger blood vessels, such as the aorta and carotid arteries, was not significantly affected in hemorrhagic DNmDia + /SM22Cre + embryos ( Figure 2C ).
A subset of DNmDia + /SM22Cre + mice also exhibited cardiac abnormalities, including ventricular septal defects and hypoplasticity of the ventricular wall and septum at E18.5 ( Figure 2D ). Because this SM22Cre line can drive Cre expression in the embryonic heart, DRF signaling was likely important for myocardial cell proliferation/survival during this developmental window. Indeed, phospho-histone H3 staining revealed a dramatic reduction in myocardial cell proliferation in DNmDia + /SM22Cre + mice. A significant number of DNmDia + /SM22Cre + mice died perinatally and although these mice appeared fairly normal at birth they quickly became runted and did not survive past postnatal day 9. All dead pups had milk in their stomach, suggesting that the runted phenotype was not because a nursing defect. Histological analysis revealed lung congestion and hearts with thin ventricular walls and low phospho-histone H3 staining again suggestive of heart defects in these mice ( Figure II SMC marker gene expression were unaffected even though DNmDia was strongly expressed in these tissues ( Figure 2E ).
DNmDia Expression Altered SMC Phenotype After Arterial Injury
It is clear that the activation of compensatory pathways during development can modify the phenotype of genetically modified mice and that the application of acute stresses can unmask previously undetected effects of genetic modifications. The lack of phenotype in adult DNmDia + /SM22Cre + provided us with an excellent model for examining the effects of mDia signaling on SMC phenotypic modulation after vascular injury.
To this end, we subjected DNmDia + /SM22Cre + and control littermates to a carotid artery ligation procedure that results in a significant neointima by 21 days and a downregulation of SMC differentiation marker gene expression in medial SMCs that peaks at ≈4 to 5 days post injury and eventually returns to normal ( Figure 3 ). 33 Notably, we observed no statistical significant difference in vessel diameter between uninjured and ligated arteries in either control or DNmDia + /SM22Cre + animals.
In excellent agreement with the Western blot data shown in Figure 2E , immunohistochemical analyses revealed no differences in SM α-actin, SM MHC, or calponin expression between uninjured arteries from control and DNmDia + / SM22Cre + mice ( Figure 3 ; Figure III in the online-only Data Supplement). As expected, differentiation marker expression in medial SMC was reduced at 4 days post ligation in control mice, and a similar reduction was observed in DNmDia + / SM22Cre + animals ( Figure 3C ). However, although SMC differentiation marker gene expression was already returning to baseline by day 7 post injury in control mice, it remained downregulated in DNmDia + /SM22Cre + mice ( Figure 3A and 3C). This difference was not apparent at the 21-day time point ( Figure 3A ), suggesting that the recovery of SMC marker gene expression was delayed but not completely inhibited in this model. Importantly, the differences in SMC marker gene expression at the 7-day time point were accompanied by reductions in MRTF-A nuclear localization ( Figure 3D ; Figure IVA in the online-only Data Supplement), an effect probably because of decreased actin polymerization in DNmDia-expressing SMC.
The ability of DNmDia to inhibit SMC marker gene expression in this model suggested that these cells were more phenotypically modulated. However, injured vessels from DNmDia + /SM22Cre + mice had significantly less neointima formation and overall stenosis than controls ( Figure  3A and 3B) and reduced collagen deposition ( Figure IVB in the online-only Data Supplement). Taken together, these data suggest that mDia signaling has differential effects on SMC phenotype and provide strong evidence that SMC differentiation and growth/migration are not mutually exclusive and are independently regulated.
Inhibition of mDia Signaling Reduced Directional SMC Migration
Extensive evidence including the results from elegant lineage tracing studies indicates that the majority of neointima SMC originate from the medial SMC layer and that injury-induced increases in SMC migration and proliferation are critical for neointima formation. 34 Although it is well known that RhoA signaling has complex and sometimes biphasic effects on these processes, 35 the role of mDia signaling in SMC is less clear. Thus, we performed additional analyses to identify the mechanism for decreased neointima formation in DNmDia + / SM22Cre + mice.
Although control mice exhibited larger neointimas than DNmDia mice at 21 days post ligation, we observed similar percentages of proliferating cells within the neointima at day 7 ( Figure 3E ). In agreement with the lack of effect on neointimal cell proliferation we observed in vivo, knockdown of mDia1, mDia2, or both in mouse aortic SMC or 10T1/2 cells had no significant effects on cell proliferation as measured by phospho-histone H3 staining or MTT assays ( Figure VA On the basis of these results and previous studies demonstrating that mDia-mediated actin polymerization was required for filopodia formation and cell migration, 23, 36 we hypothesized that the decrease in neointima size in DNmDia + / SM22Cre + mice resulted from a decrease in migration from the medial SMC layer. In strong support of this, siRNAmediated knockdown of mDia1, mDia2, or both ( Figure 4C ) resulted in a 50% to 70% decrease in SMC migration in transwell assays ( Figure 4A ) and a significant decrease in scratch wound closure in 10T1/2 cells ( Figure 4B) . Interestingly, live cell tracking studies demonstrated that subconfluent cells expressing DNmDia-mCherry were capable of random migration and that these cells migrated similar distances to control cells ( Figure 5A ). Although DNmDiaexpressing and control cells also traversed similar distances in scratch wound assays, directional migration toward the wound was significantly inhibited in DNmDia-expressing cells ( Figure 5B-5C ; Movies I and II in the online-only Data Supplement), strongly suggesting that inhibition of mDia signaling in SMC leads to defects in directional migration or cell polarity. Accordingly, DNmDia-expressing cells exhibited significant polarity defects as evidenced by lamellipodia formation in multiple directions ( Figure 5D ; Figure  VIA 
mDia Signaling Maintains SMC Differentiation in Adults
The effects of DNmDia expression in SM22-expressing cells during development were incompletely penetrant, and it is likely that stochastic differences in the timing or level of DNmDia expression during a critical developmental window helps explain these results. Compensatory pathways may also play a role and our demonstration that DNmDia had no effect on SMC function at baseline in adults, but delayed the re-expression of SMC differentiation marker gene expression after carotid injury supports this idea. To test this hypothesis further, we crossed DNmDia + mice with the SM MHC-CreER T2 line that allowed us to activate DNmDia expression specifically in SMC in adult mice, effectively by-passing any compensatory pathways activated during development. As shown in Figure IB in the online-only Data Supplement, intraperitoneal injection of tamoxifen for 5 consecutive days activated Cre in the SMC layers of the aorta, bladder, lungs, and stomach in this model although activation of DNmDia expression was somewhat more variable ( Figure 6B ; Figure  VII in the online-only Data Supplement). Importantly, tamoxifen treatment of DNmDia + /SM MHC-CreER T2 mice resulted in a significant downregulation of SM MHC gene expression in the aorta, bladder, and stomach and a significant downregulation of all SMC differentiation marker genes in the bladder that exhibited strong and consistent DNmDia expression ( Figure 6 ; Figure VII in the online-only Data Supplement). 
Discussion
To our knowledge, these results provide the first in vivo evidence that signaling through the DRFs is critical for SMC differentiation marker gene expression and proper heart development. Our results also suggest that inhibition of mDia signaling inhibits neointima formation by attenuating directed SMC migration from the medial SMC layer of injured vessels. Although 80% of DNmDia + /SM22Cre + mice exhibited no detectable phenotype, a significant number died during embryonic development or perinatally. Several embryos exhibited significant hemorrhaging, suggesting that vessel integrity was affected by SMC-specific expression of DNmDia. Although the larger vessels were properly layered with SM α-actinexpressing cells, there appeared to be defects in SMC/pericyte investment of smaller vessels. Carramusa et al 37 demonstrated that mDia1 was required for proper E-cadherin junction formation between MCF-7 cells and inhibition of EC-SMC or SMC-SMC junctions in DNmDia-expressing cells could contribute to the hemorrhage observed. This phenotype was similar to that observed in global S1P2/S1P3 receptor double knockout mice, 38 which also showed a lack of SMC/pericyte investment of smaller blood vessels. Our previous studies demonstrating that S1P and S1P-dependent RhoA signaling were critical for SMC differentiation 12, 13 provide additional functional links between these 2 models.
Many deaths were attributed to heart defects that included considerable hypoplasticity. Like many SMC differentiation markers, SM22 is expressed in the myocardium during embryonic development, and our Cre-based expression model resulted in permanent and constitutive expression of DNmDia in myocardial cells potentially as early as E8.5. 32 Thus, the defects in heart development observed were probably because of myocardial cell-autonomous effects of DNmDia on cell proliferation. Because the interventricular septum forms primarily by proliferative expansion of muscular tissue of the outer curvature, 39 the VSDs (ventricular septal defects) observed may have been because of decreased protrusion of this structure from the apical wall. However, we cannot rule out a potential effect on the endocardial cushions that contribute to the anterior portion of the interventricular septum. Several sarcomeric protein mutations cause cardiac septal defects 40 and it is possible that abnormal sarcomere organization because of defects in linear actin polymerization in DNmDia-expressing cells could be involved. Interestingly, neither knockdown of mDia1 and mDia2 nor expression of DNmDia had significant effects on proliferation in SMC. Gopinath et al 41 reported that mDia1 knockdown in c2c12 skeletal muscle cells inhibited cell cycle progression, perhaps suggesting that proliferation in striated muscles is more sensitive to mDia inhibition. Taken together, our results demonstrate that DRF signaling plays a functional role in normal cardiac development and blood vessel maturation. Nevertheless, additional studies using Cre-driver lines that are more cardiac specific will be needed to determine the precise role of mDia/DRF signaling on cardiomyocyte proliferation and heart development.
We did not detect differences in SMC marker gene expression in the DNmDia + /SM22Cre + that survived to adulthood. However, we observed developmental defects in SMC investment and vessel integrity and a delay in the re-expression of SMC marker genes after carotid artery in these animals. When coupled with the decrease in SMC marker gene expression on activation of DNmDia expression in adult SMC, these data strongly support our original hypothesis that mDia-mediated actin polymerization plays a role in the regulation of SMC phenotype in vivo. It is important to note that because DNmDia expression in our model occurs only after initial SM22 activation, we do not yet know whether mDia signaling is required for the initial differentiation of SMC or whether it is more important for SMC maturation and maintenance.
DNmDia + /SM22Cre + mice exhibited reduced neointima formation after carotid artery ligation. These results are in good agreement with a study by Touré et al, 42 who observed reduced neointimal formation in global mDia1 knockout mice. Because SM22α expression has been detected in some myeloid cells 43, 44 and macrophage infiltration has been shown to promote neointima formation, it is difficult to completely eliminate a role for these cells in our model. However, because the majority of neointima cells in our injury model are SMC, we think that mDia signaling plays a SMC autonomous role in neointimal formation most likely by promoting SMC migration from the medial layer. It is well known that mDia1 and mDia2 control linear actin polymerization 36 and are required for filopodia formation and cell migration in cultured cells [45] [46] [47] and in vivo. [48] [49] [50] Our data indicated that DNmDia expression had no effect on overall SMC movement, but instead inhibited directional migration. A growing body of evidence suggests that the DRFs have important effects on microtubule organization and on cell polarity, [51] [52] [53] [54] [55] [56] [57] and our demonstration that microtubule organizing center and lamellipodia positioning were altered in DNmDiaexpressing cells strongly supports these results. Thus, it will be critical to identify the signaling mechanisms downstream of the DRFs that regulate cell polarity in SMCs. Interestingly, the reduction in collagen deposition in the DNmDia-expressing mice after ligation suggests that MRTF-A-mediated fibrosis may contribute to the injury response. In summary, our data demonstrate that DRF-mediated actin polymerization plays a role in proper heart and vascular development, the maintenance of SMC differentiation, and directional SMC migration. These results provide important new evidence that the Rho/actin/MRTF signaling axis plays a critical role in controlling SMC phenotype and support additional studies on this pathway during cardiovascular development and disease progression. 
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None. Figure 6 . Induction of dominant-negative variant of mDia1 (DNmDia) in adult mice inhibited smooth muscle cell differentiation marker gene expression. Control and DNmDia + /smooth muscle myosin heavy chain (SM MHC)Cre + mice were injected with tamoxifen intraperitoneally for 5 consecutive days. The indicated tissues were harvested after 3 weeks, and frozen sections were immunostained for SM MHC. A, Representative images and quantification of SM MHC staining. B, Represenative Western blots for DNmDia and SM MHC expression in aorta, bladder, and stomach from wild-type (WT) and DNmDia + /SM MHCCre + mice, 3 weeks after tamoxifen treatment. C, SM MHC expression relative to α-tubulin was quantified using ImageJ and then normalized to expression in WT animals set to 1. n=at least 9 animals per genotype. *P<0.05.
